Spruce Biosciences, Inc.
SPRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001683553
No open-market purchases or sales by Spruce Biosciences, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $116.3M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Spruce Biosciences, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 31 | 1 | 44 | +14 |
| Shares | 18.2M | 1.79M | 33.8M | +17.3M (+105.2%) |
| Value | $20.0M | $1.97M | $74.5M | +$56.5M (+313.6%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Spruce Biosciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 3,928,000 | $8.68M | 0.20% |
| Carlyle Group Inc. | 2,896,518 | $6.40M | 0.19% |
| 5AM Venture Management, LLC | 2,364,000 | $5.22M | 1.34% |
| AIGH Capital Management LLC | 1,104,000 | $2.37M | 0.88% |
| Alyeska Investment Group, L.P. | 1,000,000 | $2.21M | 0.02% |
| Verition Fund Management LLC | 961,899 | $2.13M | 0.03% |
| CVI Holdings, LLC | 472,000 | $1.04M | 0.39% |
| DAFNA Capital Management LLC | 312,000 | $689.5K | 0.21% |
| Worth Venture Partners, LLC | 270,624 | $581.5K | 0.29% |
| Goldman Sachs Group Inc | 182,656 | $403.7K | 0.00% |
| Two Sigma Investments, LP | 163,165 | $360.6K | 0.00% |
| Royal Bank of Canada | 93,920 | $208.0K | 0.00% |
| Two Sigma Advisers, LP | 37,600 | $83.1K | 0.00% |
| Virtu Financial LLC | 13,722 | $30.0K | 0.00% |
| HRT Financial LP | 13,340 | $29.0K | 0.00% |
| FMR LLC | 50 | $111 | 0.00% |
Sold out (2)
Institutions that held Spruce Biosciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Logos Global Management LP | 1,000,000 | $1.10M |
| BML Capital Management, LLC | 221,830 | $243.4K |
Not filed for Q1 2023 yet (1)
Institutions that held Spruce Biosciences, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Abingworth LLP | 1,792,518 | $1.97M |